December 5, 2013
Sorry for the inconvenience but the online PD Log is not operational at the moment. We are implementing some changes that are affecting the entry of learning activities. We will put a notification here once the online PD Log is operating correctly again.
MPhA Friday Five
October 24, 2013
Nominate a colleague for an MPhA Award!
The 2014 MPhA Awards nominations are now open.
October 22, 2013
MPhA and the Manitoba Institute for Patient Safety, along with their partners, are pleased to present the virtual resource guide for pharmacists to plan and deliver presentations, discussion groups, or workshops aimed at talking with patients about ways to improve medication safety. Please be sure to review the guide, and share it with other pharmacists.
October 10, 2013
The latest newsletter is now available under Newsletters & Mailings.
XELODA (capecitabine) – Risk of Severe Skin Reactions - Hoffmann-La Roche Limited [December 3, 2013]
EXPANDED Recall of additional lots of Marcaine 0.5% (bupivacaine hydrochloride injection USP) and Marcaine E 0.25% and 0.5% (bupivacaine hydrochloride and epinephrine injection USP) due to the possibility of embedded particles in the glass vial [November 30, 2013]
Marcaine (bupivacaine hydrochloride injection USP) 0.25% (50mg/20ml) - Hospira Healthcare Corporation [November 28, 2013]
Propofol-II Injectable Emulsion 1%, (10mg/mL), 1000mg/100mL - Recall of Lot No. 29609DJ Due to Presence of Particulate Matter - Hospira Healthcare Corporation [ November 27, 2013]
ENDOMETRIN (100 mg Progesterone Effervescent Vaginal Tablets) - Voluntary Recall of Two Lots Due to a Possible Lack of Therapeutic Efficacy - Ferring Inc. [November 26, 2013]
|For more information on previously issued Health Canada Advisories, Warnings and Recalls and to subscribe, go to MedEffect Canada at http://www.hc-sc.gc.ca/dhp-mps/medeff/index_e.html or click here|